Estrella Immunopharma, Inc. (the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases, today ...

Company unlocks business growth and professional fulfillment through its newest products and solutions at the annual ...